Skip to main content
Premium Trial:

Request an Annual Quote

PCRmax Alpha Cycler 4

PCRmax (Bibby Scientific) has launched Alpha Cycler 4, the only commercially available thermal cycler to offer four totally independent blocks. Capable of performing four independent runs simultaneously, the Alpha Cycler 4 delivers high-throughput thermal cycling within a compact instrument footprint. The thermal cycler's 'quad' bay design and smart software features overcome cost and resource limitation by expediting PCR and easing operation, while delivering precise DNA amplification. The software's program wizard ensures that reaction outcomes are optimized; users simply input the forward and reverse primer sequences, define the amplicon length and source of the template, and the wizard will create a bespoke protocol for the target with optimized cycling conditions. Additionally, the software includes a recent programs list that allows users to assess and run their most commonly used programs in just two taps of the screen. Regardless of the application, the Alpha Cycler 4 is suitable for life science laboratories that wish to achieve unprecedented accuracy and reliability in their PCR experiments, PCRmax said. 

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.